Skip Over Navigation Links


Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the we​bsite may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit Updates regarding government operating status and resumption of normal operations can be found at

Maximizing Investigators' Research Award (MIRA) (R35)

MIRA provides support for the research in an investigator's laboratory that falls within the mission of NIGMS. The goal of MIRA is to increase the efficiency of NIGMS funding by providing investigators with greater stability and flexibility, thereby enhancing scientific productivity and the chances for important breakthroughs. The program will also help distribute funding more widely among the nation's highly talented and promising investigators. MIRA grants will generally be for 5 years, for both established investigators and new and early stage investigators. With the publication of PAR-17-094 the program has now expanded to include established investigators who currently hold an NIGMS R01 equivalent grant; early stage investigators may apply through PAR-17-190.

Maximizing Investigators' Research Award (R35)

Maximizing Investigators' Research Award for Early Stage Investigators (R35)

For more information about MIRA or ESI-MIRA, contact

Dr. Vernon Anderson at 301-594-3827 or Dr. Kristine Willis at 301-594-0943.

NIH Definitions of New and Early Stage Investigators, Policies, and Procedures

MIRA Current and Pending Support Model Attachment [PDF, 322KB] (Required)

New NIH Biosketch and Sample (Required) ​​​​

This page last reviewed on December 12, 2017